BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32812509)

  • 1. Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer.
    Yang G; Yang Y; Ma X; Huang L; Li W; Song X; Zhang H; Liu W; Lu J
    Technol Cancer Res Treat; 2020; 19():1533033820943244. PubMed ID: 32812509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of ERCC5 genetic polymorphisms with metastasis and recurrence of gastric cancer.
    Wang S; Chen X; Fu Y; Zhang H; Liu W; Song X; Ma X; Cheng S; Lu J
    Rev Assoc Med Bras (1992); 2021 Nov; 67(11):1538-1543. PubMed ID: 34909875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese.
    Duan Z; He C; Gong Y; Li P; Xu Q; Sun LP; Wang Z; Xing C; Yuan Y
    Gene; 2012 Dec; 511(2):274-9. PubMed ID: 22982416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between ERCC5 gene polymorphisms and breast cancer risk.
    Na N; Dun E; Ren L; Li G
    Int J Clin Exp Pathol; 2015; 8(3):3192-7. PubMed ID: 26045839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.
    He C; Duan Z; Li P; Xu Q; Yuan Y
    Anticancer Drugs; 2013 Mar; 24(3):300-5. PubMed ID: 23211354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population.
    Lu JJ; Zhang HQ; Mai P; Ma X; Chen X; Yang YX; Zhang LP
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype and diplotype analyses of variation in ERCC5 transcription cis-regulation in normal bronchial epithelial cells.
    Zhang X; Crawford EL; Blomquist TM; Khuder SA; Yeo J; Levin AM; Willey JC
    Physiol Genomics; 2016 Jul; 48(7):537-43. PubMed ID: 27235448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of SNP-SNP interactions of DNA repair gene
    Sang L; Lv Z; Sun LP; Xu Q; Yuan Y
    World J Gastroenterol; 2018 Feb; 24(5):602-612. PubMed ID: 29434449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population.
    Yang LQ; Zhang Y; Sun HF
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of ERCC5 gene polymorphisms with risk of breast cancer in Han women of northwest China.
    Wang H; Wang T; Guo H; Zhu G; Yang S; Hu Q; Du Y; Bai X; Chen X; Su H
    Breast Cancer; 2016 May; 23(3):479-85. PubMed ID: 25644244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium.
    Blomquist TM; Crawford EL; Willey JC
    Carcinogenesis; 2010 Jul; 31(7):1242-50. PubMed ID: 20233728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between ERCC5 gene polymorphisms and gastric cancer risk.
    Guo BW; Yang L; Zhao R; Hao SZ
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on association between ERCC5 single nucleotide polymorphism and susceptibility to esophageal cancer.
    Zhang C; Liao Z; Yu G; Huang W; Song X
    J BUON; 2017; 22(4):979-984. PubMed ID: 28952217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population.
    Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
    Oncol Rep; 2021 Mar; 45(3):1295-1305. PubMed ID: 33469680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population.
    Li RJ; Li M; Liu GJ; Guo YW; Bai H; Xiao P; Mei JZ
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between XPG polymorphisms and stomach cancer susceptibility in a Chinese population.
    Chen YZ; Guo F; Sun HW; Kong HR; Dai SJ; Huang SH; Zhu WW; Yang WJ; Zhou MT
    J Cell Mol Med; 2016 May; 20(5):903-8. PubMed ID: 26820236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on the role of XPG gene polymorphisms in breast cancer risk in a Chinese population.
    Ma SH; Ling FH; Sun YX; Chen SF; Li Z
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of
    Wang XQ; Terry PD; Li Y; Zhang Y; Kou WJ; Wang MX
    World J Gastroenterol; 2019 Sep; 25(34):5152-5161. PubMed ID: 31558863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPG gene polymorphisms and cancer susceptibility: evidence from 47 studies.
    Huang J; Liu X; Tang LL; Long JT; Zhu J; Hua RX; Li J
    Oncotarget; 2017 Jun; 8(23):37263-37277. PubMed ID: 28416771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.